Related Experiment Video
Updated: Jul 6, 2025
06:51
Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
33.4K
Cellular Senescence in Non-Small Cell Lung Cancer
Huangkai Zhu1, Jiaen Sun2, Chong Zhang2
1Department of Thoracic Surgery, Ningbo No.2 Hospital, 315010 Ningbo, Zhejiang, China.
Frontiers in Bioscience (Landmark Edition)
|January 5, 2024
Summary
Cellular senescence, a key factor in non-small cell lung cancer (NSCLC), presents a promising biomarker. This study analyzes senescence-associated genes, the secretory phenotype, and immune profiles in NSCLC to guide effective treatments.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Non-small cell lung cancer (NSCLC) accounts for 80% of lung cancer cases, a leading cause of cancer mortality globally.
- Cellular senescence is emerging as a significant biomarker in cancer, but its role in NSCLC requires further elucidation.
- Understanding the mechanisms of senescence in NSCLC is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To comprehensively analyze genes associated with cellular senescence in NSCLC.
- To investigate the senescence-associated secretory phenotype (SASP) in NSCLC.
- To examine the immune profile and prognostic value of senescence in NSCLC.
Main Methods:
- Bioinformatic analysis of gene expression data related to cellular senescence in NSCLC.
- Characterization of the SASP in NSCLC patient samples.
- Correlation analysis between senescence markers, immune infiltrates, and patient outcomes.
Main Results:
- Identification of key senescence-related genes implicated in NSCLC development.
- Characterization of the specific secretory phenotype associated with NSCLC senescence.
- Significant correlations found between senescence profiles, immune microenvironment, and patient prognosis.
Conclusions:
- Cellular senescence and its secretory phenotype are integral to NSCLC biology.
- Senescence markers hold potential as prognostic biomarkers for NSCLC.
- Targeting cellular senescence may offer a novel therapeutic avenue for NSCLC treatment.
Related Concept Videos
02:15Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K